InvestorPlace - Stock Market News, Stock Advice & Trading Tips
With Verrica Pharmaceuticals releasing positive Phase 3 trial results for a skin disease therapeutic, VRCA stock skyrocketed in response.
The post Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today? appeared first on InvestorPlace.
More From InvestorPlace